For example, activation of the NF-κB signaling was found to promote PMT in glioblastoma stem cells (GSCs), contributing to GBM malignant progression [71, 72], whereas its blockade in patient-derived GSCs resulted in increased sensitivity of GSCs to radiotherapy [26]. This evidence concerns the gene NFKB1 and glioblastoma.